Back to glossary
Biomarkers

Fibrinogen

Fibrinogen (coagulation factor I) is a hepatically produced 340-kDa glycoprotein that polymerises to fibrin during clot formation and is also an acute-phase reactant. It is measured by the Clauss functional assay (clot-based) or immunoassay; typical reference range is 200-400 mg/dL (2.0-4.0 g/L). Beyond its role in haemostasis, plasma fibrinogen is an independent cardiovascular risk marker: the Fibrinogen Studies Collaboration's individual-participant meta-analysis of 154,211 adults (JAMA 2005) demonstrated a hazard ratio of approximately 2.4 (95% CI 2.3–2.6) for coronary heart disease per 1 g/L higher usual fibrinogen, with similar associations for stroke and non-vascular mortality. Major confounders include acute infection or trauma (rise within 24-48 h), smoking, pregnancy, oral estrogens, malignancy, and chronic inflammation; values can be reduced in disseminated intravascular coagulation, severe liver disease, fibrinolytic therapy and congenital hypofibrinogenaemia.

Sources

  1. Fibrinogen Studies Collaboration (Danesh J, Lewington S, Thompson SG, et al.). (2005). Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. *JAMA*doi:10.1001/jama.294.14.1799
  2. Kaptoge S, Di Angelantonio E, Pennells L, et al. (Emerging Risk Factors Collaboration). (2012). C-reactive protein, fibrinogen, and cardiovascular disease prediction. *New England Journal of Medicine*doi:10.1056/NEJMoa1107477